Results 131 to 140 of about 5,666,574 (155)

Risk Factors of Thyroid Eye Disease

Endocrine Practice, 2021
Chin Meng Khoo, Gangadhara Sundar, Cheng Han Ng   +2 more
exaly  

Sphingolipids in thyroid eye disease

Frontiers in Endocrinology, 2023
Erich Gulbins, Anja Eckstein, Anne Gulbins   +2 more
exaly  

Endokrine Orbitopathie (EO) (engl. Graves’ Orbitopathy [GO], Thyroid Eye Disease [TED])

2021
Joachim Esser, Anja Eckstein
openaire   +1 more source

Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States

Endocrine Practice, 2022
Robert Holt, Lissa Silver, Megan Francis-Sedlak   +2 more
exaly  

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Ophthalmology, 2022
Mario Salvi, Raymond S Douglas, Alessandro Antonelli   +2 more
exaly  

A Systematic Review and Meta Analysis of Teprotumumab Efficacy in Treating Chronic Thyroid Eye Disease (TED)

2023
Nicholas Householder, Coby Ray
openaire   +1 more source

Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis

Endocrine Practice, 2022
Robert Holt, Lissa Silver, Megan Francis-Sedlak   +2 more
exaly  

Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018

American Journal of Ophthalmology, 2023
Qiang Zhang, James Sharpe
exaly  

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

Frontiers in Endocrinology, 2023
Gerd Krause, Ulrich Flögel, Anja Eckstein   +2 more
exaly  

Future Projections in Thyroid Eye Disease

Journal of Clinical Endocrinology and Metabolism, 2022
Mario Salvi, Giuseppe Barbesino, Suzanne Freitag   +2 more
exaly